![Pieter Oldenziel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Pieter Oldenziel has worked as a Director at Ablynx NV since 2019 and currently holds a position as Managing Director at Sanofi Foreign Participations BV.
Cargos activos de Pieter Oldenziel
| Empresas | Cargo | Inicio |
|---|---|---|
| ABLYNX | Director/Miembro de la Junta | 01/01/2019 |
Sanofi Foreign Participations BV
 Sanofi Foreign Participations BV Pharmaceuticals: GenericHealth Technology Manufactures human monoclonal antibody drugs | Director Ejecutivo | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
1
Relaciones de 1er grado
2
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Develops and produces antibodies | Health Technology |
Sanofi Foreign Participations BV
Sanofi Foreign Participations BV Pharmaceuticals: GenericHealth Technology Manufactures human monoclonal antibody drugs | Health Technology |
- Bolsa de valores
- Insiders
- Pieter Oldenziel
Elige MarketScreener 
